Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 
First in human use of Remanufactured da Vinci Xi® Robotic Instruments
HENDERSON, Nev., May 29, 2025 /PRNewswire/ -- Restore Robotics today announced that Dr. Eugene Dickens at Hillcrest Medical Center in...
Fangzhou Showcases AI-Driven Healthcare Ecosystem at PHARMCHINA as China’s Shift to Digital Medicine Accelerates
GUANGZHOU, China, May 29, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, took...
Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference
New evidence from the largest prospective evaluation of stroke AI imaging further validates Brainomix 360 Stroke impact on mechanical thrombectomy,...
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; Inhibition rate of ~90% observed in...
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family...
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...
Parexel Showcases Oncology Expertise at ASCO 2025; Company Selected to Present Five Posters at World’s Largest Oncology Event
Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting Onsite Parexel experts include recently appointed Chief Medical Officer and...
Lantern’s Cancer Program Reaches 1 Million Member Milestone
Lantern also announces clinical team and partner expansion to deliver accelerated treatmentDALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Lantern, the...
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical...
Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settingsVANCOUVER, British...
Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Organic Living Soil LLC Joins Easy Environmental Solutions as Exclusive Dealer in Louisiana and Mississippi Following Initial Shipment
WELCOME, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental...
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
New video series explores the impact of ADHD on relationships and the role of Qelbree in helping Jay’s ADHD symptom...
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant...
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani...
atai Life Sciences to Participate in Upcoming Investor Conferences
NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage...
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices...
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking...
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused...
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...